Contraline is a clinical-stage biotechnology company that develops male contraceptive solutions.
Contraline has raised $92.5M in total funding. The most recent round was Series B. The last funding was announced in June 2026.
Contraline's investors include RA Capital Management, Founders Fund, Alumni Ventures, Abstract, Y Combinator.
Contraline is headquartered in Charlottesville, United States.
Contraline is a clinical-stage biotechnology company that develops male contraceptive solutions.
Contraline is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Contraline — Funding & Investors." VCBacked, June 2, 2026, https://www.vcbacked.co/company/contraline. Accessed August 15, 2026.
VCBacked. (2026). Contraline — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/contraline
{{cite web |title=Contraline — Funding & Investors |url=https://www.vcbacked.co/company/contraline |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated